Panel recommends approval for Bepreve eye allergy drops
(Reuters) UPDATED 2009-06-30
A U.S. Food and Drug Administration advisory panel has recommended approval of Bepreve--a new drug to treat itchy eyes caused by allergies. The drops are safe for allergy sufferers as young as three, drugmaker Ista says. If it gets final FDA approval, the drug will be available only by prescription.
Read full story >
See all Allergy News